MedTrace Logo

Study to Evaluate the Feasibility of Community-based Test and Treat Strategies Among Men Who Have Sex With Men and Transgender Women to Increase the Uptake of HIV Testing and Treatment Services in Thailand

NCT02383602 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6000

Last updated 2023-02-17

No results posted yet for this study

Summary

HIV counseling and testing, risk reduction counseling, provision of condoms and lubricants Same-day result HIV testing along with pre-test and post-test counseling, including risk reduction counseling, will be provided according to the standard practice at each study site at enrollment and every 6 months in HIV-negative participants. HIV-negative participants can also access non-occupational post-exposure prophylaxis service and symptomatic STD service if these are available at study sites. HIV-positive participants will also receive risk reduction counseling every 3 months. Condoms and lubricants will be provided free of charge.

Conditions

  • HIV Test and Treat

Sponsors & Collaborators

  • United States Agency for International Development (USAID)

    collaborator FED

  • Ministry of Health, Thailand

    collaborator OTHER_GOV

  • The Government Pharmaceutical Organization

    collaborator OTHER_GOV

  • National Health Security Office, Thailand

    collaborator OTHER

  • Thai Red Cross AIDS Research Centre

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-08-15
Primary Completion
2020-10-20
Completion
2023-02-16

Countries

  • Thailand

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02383602 on ClinicalTrials.gov